Pharmaceuticals CDMO
End-to-End Solutions
We support small molecule NCEs across Phase I–III and commercial launches with regulatory starting materials, and advanced intermediates.
Our USFDA-inspected cGMP facility in Bharuch, integrated development-to-manufacturing platform and regulatory expertise ensure seamless tech transfer and inspection-ready global supply.
Three streams in ISO 8 cleanroom are designed to accommodate multiple products with diverse chemistries & operate as per global regulatory standards.
Discuss your clinical to commercial roadmap with us for your critical molecules.
Three streams in ISO 8 cleanroom are designed to accommodate multiple products with diverse chemistries & operate as per global regulatory standards.
Discuss your clinical to commercial roadmap with us for your critical molecules.
From Concept to Commercialisation
Integrated expertise across every stage of development and manufacturing
Robust Quality Management System
Quality Governance & Organization
- Defined quality policy and objectives
- Independent QA Quality organization with authority
Document Management System
- QA Controlled SOPs, BMRs, protocols, reports
- Ensuring traceability and audit readiness
Deviation, CAPA & Change Control
- Structured deviation management system & Change control system
- Root cause analysis (RCA) and effective CAPA implementation
GMP Compliance Framework
- Operated as per IHC Q7 guildlines
- Site readiness for regulatory inspections and audits
Analytical & Quality Control Systems
- Strong QC lab infrastructure
- Stability studies & data trending with Validated analytical methods
- Out-of-Specification (OOS) and Out-of-Trend (OOT) handling
Why Customers Choose Us
- Ability to handle complex chemistry (35+ chemistry platforms)
- Robust analytical development & method validation
- IP Protection & Reliability
- Supply chain risk mitigation (dual sourcing, inventory strategy)
- Advanced process development & scale-up expertise
- Flexible, compliant manufacturing with scalable capacity
- Speed, agility & responsiveness
- Cost efficiency with continuous productivity improvement
- Growing focus on sustainability & ESG
Case Studies
-b013f649-d6ba-4acf-ae9c-f7be7e81cfc4-68f87955-c5f3-4f69-ac4b-9bdbf7aec404.jpeg)
Accelerated development of 13-step intermediate to reduce time to market
Global top 15 US Pharma Co.
Explore More-b79b2e96-2abf-4b90-988b-f2f35109befc-f73e790d-b422-4697-b540-72a9f216497a.jpeg)
Scaled production for a hazardous chemistry product for a top Pharma Co
Top Japanese Pharma Co.
Explore More